Traditional Chinese medicine composition for treating pulmonary abscess

Abstract

The invention discloses a traditional Chinese medicine composition for treating pulmonary abscess. The traditional Chinese medicine composition is prepared from, by weight, 10-30 parts of flos lonicerae, 10-20 parts of radix platycodonis, 10-20 parts of radix arnebiae seu lithospermi, 5-15 parts of common bletilla tuber, 10-20 parts of herb of common turczaninowia, 10-20 parts of littleleaf Lemmaphyllum, 10-20 parts of hibiscus root, 5-15 parts of chrysanthemum flowers, 10-20 parts of the stem of noble dendrobium, 10-20 parts of rhizoma nelumbinis, 5-15 parts of rhodiola rosea, 10-20 parts of cacumen biotae, 10-20 parts of triglochin martimum, 10-20 parts of opopanax, 10-20 parts of radix fici simplicissimae, 5-15 parts of uniflower swisscentaury root, 10-20 parts of momordica grosvenori fruits, 10-20 parts of radix adenophorae, 5-15 parts of agaric, 10-20 parts of fructus forsythia, 10-20 parts of calyx kaki, 5-15 parts of common hogfenneI root, 10-20 parts of rhizoma phragmitis and 5-15 parts of liquorice roots. The traditional Chinese medicine composition has the effects of clearing away heat and toxic materials, opening the inhibited lung-energy and eliminating phlegm, promoting blood circulation to remove blood stasis and eliminating carbuncle and removing pus, and is remarkable in pulmonary abscess treatment effect, safe and reliable.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating pulmonary abscess. Background technique [0002] Pulmonary carbuncle, one of the internal carbuncles, is a relatively common disease in internal medicine. It is caused by stagnation of heat and toxins in the lungs, resulting in sores in the lung lobes, rotten flesh, and the formation of abscesses. Phlegm, and even coughing up pus and blood sputum is a disease with main clinical manifestation. Disease changes are generally divided into three phases, superficial syndrome phase: mainly manifested as aversion to cold, fever, sweating, cough and chest pain, floating and rapid pulse, etc.; Sliding number embolism; festering stage: mainly manifested as coughing, pus and bloody stench. At present, antibiotics are usually used to treat lung abscess clinically. The initial effect is obvious,...

AI Technical Summary

Problems solved by technology

At present, antibiotics are usually used clinically to treat pulmonary abscess. The initial effect is obvious, but over time, it is easy to form drug dependence, and it is easy to relapse after stopping the drug.